Aurinia Pharmaceuticals

After hunt for buyer fails, Aurinia lays off 25%, drops R&D

Aurinia searched hard for a buyer, but, faced with a lack of offers, the biotech has resorted to trimming its workforce and cleaning out its pipeline.

James Waldron Feb 15, 2024 8:25am

Patients undergoing kidney dialysis must have their hydration level closely monitored a newly-developed portable sensor make

Aurinia pays $7M for 2 preclinical assets after January FDA nod

Aug 17, 2021 11:56am

Aurinia ditches would-be Restasis rival after phase 2/3 fail

Nov 2, 2020 5:05pm

Aurinia soars as phase 3 lupus study hits primary endpoint

Dec 5, 2019 7:30am